Sign In
Buy ARDX
$6.18
-0.190 (-2.98%)
At Close: Jun 23, 2026
Ardelyx (ARDX) Reports Q1 Loss, Tops Revenue Estimates
07:02pm, Wednesday, 03'rd May 2023
Ardelyx (ARDX) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.21 per share a year ago.
Ardelyx to Report First Quarter 2023 Financial Results and Provide Business Update on May 3, 2023
08:00am, Wednesday, 26'th Apr 2023
WALTHAM, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class me
Ardelyx: Underappreciated Biotech With Potential FDA Approval On Deck
03:34am, Monday, 24'th Apr 2023
Ardelyx: Underappreciated Biotech With Potential FDA Approval On Deck.
Top Penny Stocks To Buy Now? 10 To Watch Under $5
11:27am, Thursday, 13'th Apr 2023
10 Penny stocks under $5 to watch right now The post Top Penny Stocks To Buy Now? 10 To Watch Under $5 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
3 Penny Stocks to Add to Your Watchlist for Potential Breakouts
08:29am, Tuesday, 11'th Apr 2023
As an investor, it is essential to have a diverse range of stocks within a portfolio. Penny stocks may not make up most of someone's holdings, but they are a crucial investment addition.
7 Top Penny Stocks Under $5; Time To Buy Now?
11:28am, Wednesday, 29'th Mar 2023
Penny stocks to watch before next week. The post 7 Top Penny Stocks Under $5; Time To Buy Now?
4 Top Penny Stocks To Watch With Big Biotech News This Quarter
10:44am, Wednesday, 08'th Mar 2023
4 biotech penny stocks to watch right now. The post 4 Top Penny Stocks To Watch With Big Biotech News This Quarter appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Ardelyx Regulatory Catalyst Looms In April, But Invest In It Longer
08:00am, Monday, 06'th Mar 2023
Ardelyx's sole marketed drug can't keep the company afloat by itself until it gets broader insurance coverage. The company is resubmitting a new drug application as early as next month.
3 Penny Stocks Insiders Are Active In, Time To Buy Or Sell Now?
11:03am, Friday, 03'rd Mar 2023
Penny stocks insiders are selling? What the details suggest.
Ardelyx, Inc. (ARDX) Q4 2022 Earnings Call Transcript
10:22pm, Thursday, 02'nd Mar 2023
Ardelyx, Inc. (NASDAQ:ARDX ) Q4 2022 Earnings Conference Call March 2, 2023 4:30 PM ET Company Participants Caitlin Lowie - VP, Corporate Communications and IR Mike Raab - President and CEO Justin Ren
Ardelyx (ARDX) Surpasses Q4 Earnings and Revenue Estimates
06:49pm, Thursday, 02'nd Mar 2023
Ardelyx (ARDX) delivered earnings and revenue surprises of 500% and 59.45%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Are Medical Stocks Lagging Ardelyx (ARDX) This Year?
11:18am, Monday, 20'th Feb 2023
Here is how Ardelyx (ARDX) and Agile Therapeutics (AGRX) have performed compared to their sector so far this year.
Ardelyx Inc. (ARDX) to Report Q4 Earnings: What's in Store?
10:32am, Wednesday, 15'th Feb 2023
Ardelyx (ARDX) is expected to report better-than-expected sales growth of its only marketed product, Ibsrela (tenapanor) and provide an update on the NDA resubmission timeline for Xphozah, tenapanor.
A Short Guide to Making Money With Penny Stocks in 2023
11:00am, Saturday, 04'th Feb 2023
Use these tips for making money with penny stocks The post A Short Guide to Making Money With Penny Stocks in 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.co
